Effect of EMD 57445, the selective σ receptor ligand, on the turnover and release of dopamine

Polish Journal of Pharmacology

Volumn 50, Issue 1, 1998, Pages 61-64

  Skuza, Grazyna ^a   Gołembiowska, Krystyna ^a   Wȩdzony, Krzysztof ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

receptors; DOPAC; Dopamine; EMD 57445; HVA; Microdialysis; Rat brain structures; Tissue levels

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; NEUROLEPTIC AGENT; PANAMESINE; SIGMA RECEPTOR LIGAND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG EFFECT; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RAT; TISSUE LEVEL;

ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; DOPAMINE; MALE; MICRODIALYSIS; OXAZOLES; PIPERIDINES; RATS; RATS, WISTAR;

EID: 2642705876     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Bartoszyk G. D., Bender H. M., Hellmann J., Schnorr C., Seyfried C. A.: EMD 57445: a selective sigma receptor ligand with the profile of an atypical neuroleptic. CNS Drug Rev., 1996, 2, 175-194.
2. Gołembiowska K.: Ipsapirone, a new anxiolytic drug, stimulates catecholamine turnover in various regions of the rat brain. Pol. J. Pharmacol. Pharm., 1990, 42, 143-150.
3. Maj J., Rogóż Z., Skuza G., Mazela H.: Neuropharmacological profile of EMD 57445, a sigma receptor ligand with potential antipsychotic activity. Eur. J. Pharmacol., 1996, 315, 235-243.
4. Martin W. R., Eades C. E., Thompson J. A., Huppler R. E.: The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther., 1976, 197, 517-532.
5. Matsuno K., Matsunaga K. H., Mita S.: Acute effects of o ligands on the extracellular DOPAC level in rat frontal cortex and striatum. Neurochem. Res., 1995, 20, 233-238.
6. Paxinos G., Watson C.: The rat brain in stereotaxic coordinates. Academic Press, San Diego, 1986.
7. Skuza G., Dziedzicka-Wasylewska M., Kolasiewicz W., Maj J.: The effect of local intracerebral administration of EMD 57445, a selective σ receptor ligand, on the locomotor activity of the rat. J. Neural Transm., in press.
8. Soares-Da-Silva P., Garrett M. C.: A kinetic study of the rate of formation of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the brain of the rat: implications for the origin of DOPAC. Neuropharmacology, 1990, 29, 869-874.
9. Wȩdzony K., Golembiowska K., Zazula M.: Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats. Naunyn-Schmied. Arch. Pharmacol., 1994, 350, 555-562.
10. Zetterström T., Sharp T., Ungerstedt U.: Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis. Eur. J. Pharmacol., 1985, 106, 27-37.